Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRISIS Study: Brequinar in Hospitalized COVID-19
NCT04425252Phase 2Completed
- Sponsor
- Clear Creek Bio
- Start
- Aug 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brequinar sodium in coronavirus disease 2019 (COVID-19), sponsored by Clear Creek Bio. Started Aug 2020; status: completed.
02
Drugs
brequinar sodium
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04425252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04425252.